Anthracycline-based chemotherapy in early breast cancer: Correlation with receptor status (estrogen, progesterone and human epidermal growth factor-2 / Ahmed Abdelhamed Elsayed Oda ; Supervised Rabab Mohamed Gaafar , Ahmed Abdelmabood Zeeneldin , Amani Mohamed Helal
Material type:
- العلاج الكيماوى بالانثراسيكلين فى سرطان الثدى المبكر و علاقته بحالة المستقبلات: الاستروجين و البروجستيرون و الهير 2 نيو [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2010.Ah.A (Browse shelf(Opens below)) | Not for loan | 01010110054182000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.19.04.M.Sc.2010.Ah.A (Browse shelf(Opens below)) | 54182.CD | Not for loan | 01020110054182000 |
Thesis (M.Sc.) - Cairo University - National Cancer Institute - Department of Oncology-Medical
Breast cancer (BC) is a heterogeneous disease that encompasses several distinct entities with different biological characteristics and clinical behavior. The purpose of this study is to correlate between the outcome of early breast cancer patients who received anthracycline-based chemotherapy with the tumor receptor status namely estrogen, progesterone and HER-2 receptor as regard disease free survival and overall survival
Issued also as CD
There are no comments on this title.